The prospects for new treatments for prostate cancer

Editorial

Jack F Fowler et al. Int J Radiat Oncol Biol Phys. 2002.

. 2002 Jan 1;52(1):3-5.

doi: 10.1016/s0360-3016(01)02665-7.

No abstract available

Comment in

In regard to Brenner et al. Direct evidence that prostate tumors show high sensitivity to fractionation (low alpha/beta ratio) similar to late-responding normal tissue.
Lee WR. Lee WR. Int J Radiat Oncol Biol Phys. 2002 Aug 1;53(5):1392; author reply 1393. doi: 10.1016/s0360-3016(02)02859-6. Int J Radiat Oncol Biol Phys. 2002. PMID: 12128142 No abstract available.
Prostate cancer: low alpha/beta the only consideration? In regard to Fowler, Chappell, and Ritter: the prospects for new treatments for prostate cancer.
Denham JW. Denham JW. Int J Radiat Oncol Biol Phys. 2002 Aug 1;53(5):1394-5; author reply 1395. doi: 10.1016/s0360-3016(02)02872-9. Int J Radiat Oncol Biol Phys. 2002. PMID: 12128146 No abstract available.

Direct evidence that prostate tumors show high sensitivity to fractionation (low alpha/beta ratio), similar to late-responding normal tissue.
Brenner DJ, Martinez AA, Edmundson GK, Mitchell C, Thames HD, Armour EP. Brenner DJ, et al. Int J Radiat Oncol Biol Phys. 2002 Jan 1;52(1):6-13. doi: 10.1016/s0360-3016(01)02664-5. Int J Radiat Oncol Biol Phys. 2002. PMID: 11777617